Ładuje się......
Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers
Over the past few years, multiple immune checkpoint blockers (ICBs) have achieved unprecedented clinical success and have been approved by regulatory agencies for the treatment of an increasing number of malignancies. However, only a limited fraction of patients responds to ICBs employed as a standa...
Zapisane w:
| Wydane w: | Semin Cancer Biol |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6004231/ https://ncbi.nlm.nih.gov/pubmed/29258856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2017.12.007 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|